Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-05

Clinical Trial Update: Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of acetylsalicylic acid (aspirin) and pseudoephedrine for the common cold has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • Pseudoephedrine (Pseudoephedrine)

Snippet

Sponsor: Bayer | Conditions: Common Cold | Phase 3 | Status: COMPLETED